CEVENTRIX™ is now available!
We are proud to have reached the milestone where CEVENTRIX™ is finally available for sales!
DAHRT Biocare AS is a small Norwegian startup that has been working on the preparation for launching our first product CEVENTRIX™ for more than a year. CEVENTRIX™ is specially formulated to meet the dietary needs of people with Multiple Sclerosis (MS).
The appealing science behind the short chain fatty acid, propionate, made it clear for us that such a product should be made available to people with MS. The regulatory category for the product is “Food for Special Medical Purposes”, which means the product can target people with MS specifically. Research has shown that people with MS seem to have a deficiency in propionate levels, which can result in abnormal immune function.
DAHRT Biocare received funding from Innovation Norway to make it possible to develop the product and make it commercially available. We are truly grateful for the trust and support from Innovation Norway.
Please reach out to us if you have any questions about the product at info@ceventrix.com
English (UK) 
Norsk bokmål